Ads
related to: treatment for bladder cancer pdf- Full Prescribing Info
View Prescribing Information
On The Official HCP Website.
- Clinical Trial Data
View Clinical Trial Results
And See Efficacy Data.
- Important Safety Info
See Safety Info & Learn
About Adverse Reactions.
- Dosing Information
See Dosing & Administration
Info For HCPs.
- Full Prescribing Info
Search results
Results From The WOW.Com Content Network
Nogapendekin alfa inbakicept, sold under the brand name Anktiva, is a fixed-dose combination medication used for the treatment of bladder cancer. [1] It is an interleukin-15 receptor agonist. [1] It is given in combination with Bacillus Calmette-Guérin via intravesical drug delivery. [1]
Bladder cancer is most common in wealthier regions of the world, where exposure to certain carcinogens is highest. It is also common in places where schistosome infection is common, such as North Africa. [47] Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2]
Several cancer vaccines use BCG as an additive to provide an initial stimulation of the person's immune system. [citation needed] BCG is used in the treatment of superficial forms of bladder cancer. Since the late 1970s, evidence has become available that the instillation of BCG into the bladder is an effective form of immunotherapy in this ...
The safety and effectiveness of nadofaragene firadenovec was evaluated in a multicenter clinical study (Study CS-003 (NCT02773849)) that included 157 participants with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer, 98 of whom had BCG-unresponsive carcinoma in situ with or without papillary tumors and could be evaluated for response.
Morales' research on the treatment, published in 1976, has been described as "the seminal paper on the use of intravesical BCG in human patients" [14] and was hailed by the Journal of Urology as one of the most important papers on bladder cancer research in the past 100 years.
The term "induction regimen" refers to a chemotherapy regimen used for the initial treatment of a disease. A " maintenance regimen " refers to the ongoing use of chemotherapy to reduce the chances of a cancer recurring or to prevent an existing cancer from continuing to grow.
Ads
related to: treatment for bladder cancer pdf